News

U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.
The gene therapy chief wanted to block fast-track drug approvals.
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...
Vinay Prasad recently drew outrage from conservatives, including Laura Loomer, who disagreed with his approach to approving ...
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.
The U.S. Food and Drug Administration's top official, Vinay Prasad, has left the agency after nearly three months as Director ...
Vinay Prasad, a top regulator at the US Food and Drug Administration, ended his short tenure at the agency after conservative ...
Robby Soave and Niall Stanage discuss the unexpected ouster of one of the FDA's top regulators after receiving blowback from ...
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...